MORGAN STANLEY PLC/CALL/GERRESHEIMER/152/0.1/20.09.24 Share Price

Warrant

DE000ME1AFQ2

Market Closed - Bid/Ask 09:54:26 06/06/2024 pm IST After market 11:30:04 pm
0.62 EUR +1.64% Intraday chart for MORGAN STANLEY PLC/CALL/GERRESHEIMER/152/0.1/20.09.24 0.645 +4.03%
Current month+1.67%
1 month-6.15%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
06/24/06 0.62 +1.64%
05/24/05 0.61 -1.61%
04/24/04 0.62 +1.64%
03/24/03 0.61 +1.67%
31/24/31 0.6 +1.69%

Delayed Quote Börse Stuttgart

Last update June 06, 2024 at 09:54 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying GERRESHEIMER AG
Issuer Morgan Stanley
WKN ME1AFQ
ISINDE000ME1AFQ2
Date issued 28/09/2023
Strike 152
Maturity 20/09/2024 (106 Days)
Parity 10 : 1
Emission price 0.24
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.85
Lowest since issue 0.34
Spread 0.05
Spread %7.46%

Company Profile

Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.
Sector
-
More about the company

Ratings for Gerresheimer AG

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Gerresheimer AG

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
107.1 EUR
Average target price
134.8 EUR
Spread / Average Target
+25.89%
Consensus